Pharm
Radioiodine
search
Radioiodine
, Radioactive Iodine, I-131
Indications
Management of choice for
Grave's Disease
of all ages (most common treatment in U.S.)
Recurrent
Hyperthyroidism
after
Antithyroid Drug
s
Toxic Multinodular Goiter
Toxic
Nodule
in patient over age 40 years
Contraindications
Pregnancy
Moderate or Severe
Graves Orbitopathy
, esp.
Tobacco
users
Radioactive Iodine may worsen orbitopathy
Mild
Graves Orbitopathy
may be concurrently treated with
Corticosteroid
s
Pharmacokinetics
Half-Life
of I-131: 9 days
Effects nos seen for over 3-4 weeks
Mechanism
Concentrates in and destroys
Thyroid
tissue
Precautions
Background
Radio-
Iodine
excreted in urine,
Saliva
, feces
Most is eliminated in first 48 hours
For first 3 days
Avoid contact with children and pregnant women
For first few weeks
Double flush toilet
Wash hands carefully
Adverse Effects
No increased risk of Cancer Death
Radiation-Induced Thyroiditis
Acute Thyroiditis
in first 1-2 weeks post-I131
Slight increased risk of
Thyroid Cancer
Graves Disease
predisposes to
Thyroid Cancer
Cancers may have been present before I-131
Graves Ophthalmopathy may worsen on I-131
Occurs more commonly in
Tobacco Abuse
Prednisone
used to minimize this effect
Dose: 40-80 mg daily
Taper dose over 3 months
Efficacy
Euthyroid or Hypothyroid after symptoms
Euthyroid at 6-8 weeks after I-131: 50 to 75%
Euthyroid after one dose I-131: 80 to 90%
Labs
Urine Pregnancy Test
Obtain within 48 hours prior to Radioactive Iodine administration
Protocols
Stop all medications containing
Iodine
before
Iodine
(at least 2-3 weeks)
Avoid large
Iodine
doses (e.g. iodinated contrast or
Amiodarone
) within 3 months prior to Radioiodine ablation
Avoid pregnancy for 6 months after Radioiodine exposure
Obtain
Pregnancy Test
within 48 hours of administration
Management
Adverse Effects
Beta Blocker
s control symptoms around radio-
Iodine
Concurrent use with
Antithyroid Drug
s (e.g. PTU,
Methimazole
)
Indications
Consider if on antithyroid medication prior to Radioiodine
May be helpful in severe
Hyperthyroidism
Protocol near time of radio-
Iodine
treatement
Stop
Antithyroid Drug
s 5 days before radio-
Iodine
Restart
Antithyroid Drug
s 3-5 days after radio-
Iodine
Continue
Antithyroid Drug
s for 3 months then taper
Management
Follow-up
Obtain
Free T4
and
Free T3
at 4-8 weeks after ablation and then every 8-12 weeks until stable
Expect permanent
Hypothyroidism
at 2-6 months after Radioiodine ablation
Initiate low dose
Thyroid Replacement
as
Hypothyroidism
develops
References
Type your search phrase here